Mammoth Biosciences Further Strengthens IP Portfolio with Exclusive License to Novel Micro-Sized CRISPR Proteins

https://www.webwire.com/ViewPressRel.asp?aId=262649
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.